Dr. Yeh graduated the medical school from the State University of New York Upstate Medical University and completed his residency program at the North Shore-Long Island Jewish Health System. A fellowship followed at the University of Texas Health Science Center soon after that. He is specialized and board certified in Oncology. Dr. Yeh has been in practice for more than 11 years and during his career, he has also contributed to 17 publications of medical interest.
State University of New York Upstate Medical University
North Shore-Long Island Jewish Health System
University of Texas Health Science Center
American Board of Internal Medicine - Oncology
Delaying skeletal-related events in a randomized phase 3 study of denosumab versus zoledronic acid in patients with advanced cancer: an analysis of data from patients ...
Henry, D.,Vadhan-Raj, S.,Hirsh, V.,von Moos, R.,Hungria, V.,Costa, L.,Woll, P. J.,Scagliotti, G.,Smith, G.,Feng, A.,Jun, S.,Dansey, R.,Yeh, H.; Support Care Cancer. 2013 Oct 29.See more >>
A phase I/II study of arsenic trioxide/bortezomib/ascorbic acid combination therapy for the treatment of relapsed or refractory multiple myeloma.
Berenson, J.R., Matous, J., Swift, R.A., Mapes, R., Morrison, B., Yeh, H.S.; Clin Cancer Res. 2007 Mar 15.See more >>
Arsenic compounds in the treatment of multiple myeloma: a new role for a historical remedy.
Berenson, J.R., Yeh, H.S.; Clin Lymphoma Myeloma. 2006 Nov.See more >>